Product Program year 2025 Source: CMS Open Payments

Raldesy

Drug Cns

NDC 30698-455-02

Open in the dashboard

General payments

$9,675

497 payments

Research payments

$0

0 payments

Through program year 2025, $9,675 in general payments and $0 in research payments were reported against Raldesy (Cns).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $9,675 497

Breakdown

Who paid General payments · program year 2025
  1. Validus Pharmaceuticals LLC $9,675 497 payments
Top recipients General payments · program year 2025
  1. Nina Anderson Psychiatry · Sterling Heights, MI $278 3% · 7 payments
  2. Robert Burnstein Psychiatry · Sterling Heights, MI $248 3% · 16 payments
  3. Robert Garcia Child & Adolescent Psychiatry · Northville, MI $226 2% · 15 payments
  4. Patrick Cooney Physician Assistant · New Baltimore, MI $218 2% · 15 payments
  5. Oladele Adebogun Psychiatry · Flower Mound, TX $208 2% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Psychiatry Psychiatry & Neurology $3,784 40% · 72 practitioners
  2. Nurse Practitioner, Psychiatric/Mental Health Nurse Practitioner $1,793 19% · 55 practitioners
  3. Physician Assistant $1,196 13% · 17 practitioners
  4. Child & Adolescent Psychiatry Psychiatry & Neurology $530 6% · 9 practitioners
  5. Internal Medicine $492 5% · 13 practitioners

The top 5 of 21 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Michigan $3,220 33% · 55 recipients
  2. Texas $2,484 26% · 64 recipients
  3. Florida $2,132 22% · 43 recipients
  4. New York $934 10% · 23 recipients
  5. New Jersey $467 5% · 21 recipients

The top 5 of 11 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

497 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record